Interferon Alpha and Pamidronate in Osteoporosis with Fracture Secondary to Mastocytosis

Abstract Background The mechanism of osteoporosis with fracture secondary to mastocytosis is little known, and its treatment is poorly codified. Methods Ten patients with a mean age of 52.5 years with systemic mastocytosis and osteoporotic fractures were treated with interferon alpha 1.5 million U 3...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of medicine 2011-08, Vol.124 (8), p.776-778
Hauptverfasser:	Laroche, Michel, MD, Livideanu, Christina, MD, Paul, Carle, MD, Cantagrel, Alain, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antiviral drugs Biological and medical sciences Bone Density - drug effects Bone Density Conservation Agents - administration & dosage Bone Density Conservation Agents - therapeutic use Clinical outcomes Diphosphonates - administration & dosage Diphosphonates - therapeutic use Diseases of the osteoarticular system Drug Therapy, Combination Female Fractures General aspects Humans Interferon alpha Interferon-alpha - administration & dosage Interferon-alpha - therapeutic use Internal Medicine Male Mastocytosis Mastocytosis - complications Medical sciences Medical treatment Middle Aged Osteoporosis Osteoporosis - complications Osteoporosis - etiology Osteoporosis. Osteomalacia. Paget disease Osteoporotic Fractures - drug therapy Osteoporotic Fractures - etiology Pamidronate Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!